Advertisement Pharmaceutical Business review -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
May 22, 2019

Merck to buy Peloton Therapeutics in £1.72bn deal

Merck has signed an agreement to acquire Peloton Therapeutics, a US-based clinical-stage biopharmaceutical firm, in a deal valued at around $2.2bn (£1.72bn).

Continue
Image: Merck has agreed to acquire US-based clinical-stage biopharmaceutical firm Peloton Therapeutics. Photo: courtesy of Adam Radosavljevic / Pixabay.
May 21, 2019

Catalent wraps up $1.2bn acquisition of gene therapy CDMO Paragon

Image: Gene therapy CDMO Paragon has been acquired by Catalent. Photo: courtesy of PublicDomainPictures/Pixabay.
May 17, 2019

Pfizer’s blood clot drug Fragmin gets FDA approval for pediatric patients

Image: FDA expands approval of Pfizer’s blood clot drug Fragmin to cover pediatric patients. Photo: courtesy of Coolcaesar/Wikipedia.org.

Contracts

March 11, 2019

TaiwanJ Pharmaceuticals out-licenses liver drug candidate in Asia

Image: TaiwanJ Pharmaceuticals obtained $26m deal for licensing and co-development contract with Newsoara Biopharma on JKB-122 Asian rights. Photo: courtesy of rawpixel/Unsplash.com.

GeoVax, Leidos expand collaboration to malaria vaccines

World’s largest pharmaceutical firm selects ValGenesis to standardize corporate validation process enterprise-level

Amprologix wins DHSC backing for new antibiotic

Deals

Deals May 20, 2019

Ligand licenses VER250840 to Cumulus Oncology

Pharmaceutical Business Review

Thermo Fisher Scientific to acquire manufacturing site in Cork, Ireland, from GSK

ESSA Pharma to acquire Realm Therapeutics

Novartis to buy Takeda’s dry eye drug Xiidra for $3.4bn

Popular

  1. SpringWorks Therapeutics initiates phase 3 trial of Nirogacestat in desmoid tumors
  2. AstraZeneca says Symbicort as anti-inflammatory reliever reduces attacks in mild asthma
  3. US FDA approves GATTEX for children with short bowel syndrome
  4. Pfizer’s Abrocitinib yields positive results in phase 3 moderate to severe AD trial
  5. Allegro announces positive results of ex-US proof-of-concept trial with ALG-1007 for dry eye disease

PRESS RELEASES

Upcoming Pharma Training from NSF
Upcoming Pharma Training from NSF
Pfanstiehl Launches cGMP-Produced, Parenteral-Grade Mannitol
Pfanstiehl Launches cGMP-Produced, Parenteral-Grade Mannitol
Join Royal Pharmaceutical Society’s 16th Joint Qualified Person Symposium
Join Royal Pharmaceutical Society’s 16th Joint Qualified Person Symposium
Injecting Beauty Made Easy
Injecting Beauty Made Easy
Rethinking Pharma Packaging
Rethinking Pharma Packaging

Suppliers

Whitepapers

Validated Metal Analysis of Injectable Grade Platform Excipients
Validated Metal Analysis of Injectable Grade Platform Excipients
Narrowing the Gap Between Active Ingredients and Critical Excipients
Narrowing the Gap Between Active Ingredients and Critical Excipients
Trehalose: A Powerful Excipient in the Formulation Toolbox
Trehalose: A Powerful Excipient in the Formulation Toolbox